Factor IX a inhibition contributes to the heparin effect.
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thrombin formation that is observed at therapeutic concentrations of heparin. The action of standard unfractionated heparin (0.05 U/ml) on thrombin formation in the intrinsic system was compared to that of a mixture of dermatan sulfate (DS) and a synthetic pentasaccharide (PS). DS enhances the action of heparin cofactor II which inhibits thrombin only. PS specifically enhances the anti-factor Xa activity of antithrombin III (AT III). The concentrations of DS and PS were chosen so as to obtain equal anti-thrombin and anti-factor Xa activities as in 0.05 U/ml heparin. An extra inhibitory effect of heparin over the mixture is observed in situations where free factor IXa, not bound to factor VIIIa and phospholipid, limits the rate of thrombin formation, notably in contact activated plasma. We conclude that the inactivation of free factor IXa by heparin contributes importantly to the inhibition of thrombin formation in the intrinsic system such as e.g. measured in the activated partial thromboplastin time.
Béguin
S
S
Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.
Dol
F
F
Hemker
H C
HC
D003871:Dermatan Sulfate / Q000494:pharmacology; D015949:Factor IXa / Q000037:antagonists & inhibitors*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D009844:Oligosaccharides / Q000494:pharmacology*; D013917:Thrombin / Q000096:biosynthesis*
D009844:Oligosaccharides; D003871:Dermatan Sulfate; D006493:Heparin; D015949:Factor IXa; D013917:Thrombin